Quick Answer
MindMaze Therapeutics Holding SA reported Total Assets of $76.39 million for fiscal year 2023.
MindMaze Therapeutics Holding SA — Key Financials by Year
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Total Assets | $76.39M -59.5% |
$188.80M -25.0% |
$251.62M |
| R&D Expense | $1.33M -89.3% |
$12.39M -34.9% |
$19.02M |
- MindMaze Therapeutics Holding SA reported Total Assets of $76.39 million for fiscal year 2023.
- MindMaze Therapeutics Holding SA showed a decrease of -59.5% in Total Assets compared to the prior fiscal year.
- MindMaze Therapeutics Holding SA reported R&D Expense of $1.33 million for fiscal year 2023.
- MindMaze Therapeutics Holding SA showed a decrease of -89.3% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: